These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16319541)

  • 1. Association between achieving treatment goals for lipid-lowering and cardiovascular events in real clinical practice.
    Lindgren P; Borgström F; Stålhammar J; Alemao E; Yin DD; Jönsson L
    Eur J Cardiovasc Prev Rehabil; 2005 Dec; 12(6):530-4. PubMed ID: 16319541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of care for patients treated with lipid-lowering drugs.
    Carlsson A; Borgström F; Stålhammar J; Alemao E; Yin D; Jönsson L
    Pharmacoeconomics; 2004; 22 Suppl 3():25-35. PubMed ID: 15669151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term achievement of the therapeutic objectives of lipid-lowering agents in primary prevention patients and cardiovascular outcomes: an observational study.
    Van Ganse E; Souchet T; Laforest L; Moulin P; Bertrand M; Le Jeunne P; Chretin S; Yin D; Alemao E; de Pouvourville G
    Atherosclerosis; 2006 Mar; 185(1):58-64. PubMed ID: 16038912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-lowering drug use and cardiovascular events after myocardial infarction.
    Klungel OH; Heckbert SR; de Boer A; Leufkens HG; Sullivan SD; Fishman PA; Veenstra DL; Psaty BM
    Ann Pharmacother; 2002 May; 36(5):751-7. PubMed ID: 11978147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study.
    García Ruiz FJ; Marín Ibáñez A; Pérez-Jiménez F; Pintó X; Nocea G; Ahumada C; Alemao E; Yin D;
    Pharmacoeconomics; 2004; 22 Suppl 3():1-12. PubMed ID: 15669149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of retrospective chart review to determine improvement in lipid goal attainment in patients treated by high-volume prescribers of lipid-modifying drugs.
    Stacy TA; Egger A
    J Manag Care Pharm; 2006; 12(9):745-51. PubMed ID: 17249907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin utilization patterns for the primary prevention of cardiovascular events: a retrospective study in patients with diabetes mellitus in Hong Kong.
    Lee VW; Ho IC; Chan WS; Tam KY; Lee KK
    Am J Cardiovasc Drugs; 2008; 8(3):199-205. PubMed ID: 18533740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best practice--ongoing polemics.
    Paoletti R; Bellosta S
    Atherosclerosis; 1999 May; 143 Suppl 1():S3-6. PubMed ID: 10382831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO.
    Nag SS; Daniel GW; Bullano MF; Kamal-Bahl S; Sajjan SG; Hu H; Alexander C
    J Manag Care Pharm; 2007 Oct; 13(8):652-63. PubMed ID: 17970603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk factors and recommended lipid goals attainment among patients referred in a tertiary care lipid clinic.
    Pirro M; Del Giorno R; Lupattelli G; Mannarino MR; Roscini AR; Covelli D; Schillaci G; Pasqualini L; Bagaglia F; Siepi D; Mannarino E
    Eur J Intern Med; 2011 Aug; 22(4):412-7. PubMed ID: 21767761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact on cardiovascular events of increasing high density lipoprotein cholesterol with and without lipid lowering drugs.
    Wei L; Murphy MJ; MacDonald TM
    Heart; 2006 Jun; 92(6):746-51. PubMed ID: 16216856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A change of attitude in lipidology, achievement of target levels. What comes next?].
    Márk L; Dani G; Kiss Z; Katona A
    Orv Hetil; 2008 Sep; 149(37):1731-6. PubMed ID: 18805756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Treatment for Hyperlipidemia with Decreased Total Mortality in Japanese Individuals: the Yamagata (Takahata) Study.
    Daimon M; Oizumi T; Kameda W; Matsui J; Murakami H; Ueno Y; Kubota I; Yamashita H; Kayama T; Kato T
    J Atheroscler Thromb; 2015; 22(10):1030-9. PubMed ID: 26016512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More Nuanced Guidelines for Lipid Lowering to Prevent CVD.
    Shaughnessy AF
    Am Fam Physician; 2016 Jan; 93(1):59. PubMed ID: 26760843
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery.
    Lindenauer PK; Pekow P; Wang K; Gutierrez B; Benjamin EM
    JAMA; 2004 May; 291(17):2092-9. PubMed ID: 15126437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol in women at high cardiovascular risk is less successfully treated than in corresponding men. The Skaraborg Hypertension and Diabetes Project.
    Mehner A; Lindblad U; Råstam L; Boström KB
    Eur J Clin Pharmacol; 2008 Aug; 64(8):815-20. PubMed ID: 18389228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New strategies for the development of lipid-lowering therapies to reduce cardiovascular risk.
    Graham I; Shear C; De Graeff P; Boulton C; Catapano AL; Stough WG; Carlsson SC; De Backer G; Emmerich J; Greenfeder S; Kim AM; Lautsch D; Nguyen T; Nissen SE; Prasad K; Ray KK; Robinson JG; Sasiela WJ; Bruins Slot K; Stroes E; Thuren T; Van der Schueren B; Velkovski-Rouyer M; Wasserman SM; Wiklund O; Zouridakis E;
    Eur Heart J Cardiovasc Pharmacother; 2018 Apr; 4(2):119-127. PubMed ID: 29194462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipids and Cardiovascular Disease: Putting It All Together.
    Pownall HJ; Gotto AM
    Methodist Debakey Cardiovasc J; 2019; 15(1):5-8. PubMed ID: 31049143
    [No Abstract]   [Full Text] [Related]  

  • 19. Gender differences in achieving optimal lipid goals in patients with coronary artery disease.
    Victor BM; Teal V; Ahedor L; Karalis DG
    Am J Cardiol; 2014 May; 113(10):1611-5. PubMed ID: 24698458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ineffectiveness of lipid-lowering therapy in primary care.
    Van Ganse E; Souchet T; Laforest L; Moulin P; Bertrand M; Le Jeunne P; Travier N; Yin D; Alemao E; de Pouvourville G
    Br J Clin Pharmacol; 2005 Apr; 59(4):456-63. PubMed ID: 15801941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.